Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peritoneal Ultrafiltration in Treatment-Resistant Heart Failure
NCT00368641Phase 2Terminated
- Sponsor
- Vanttive
- Start
- Aug 2006
- Primary completion
- Apr 2008
- Modality
- Polymer-based Nanoparticles, Device-based Delivery
- Countries
- 4
01
Overview
A Phase 2 trial of icodextrin in heart failure (HF), sponsored by Vanttive. Started Aug 2006; status: terminated.
02
Drugs
icodextrin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00368641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368641.